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xid is an X-linked recessive allele carried by CBA/N mice and their hemizygous
F, male progeny (F, males). This gene confers susceptibility to Salmonella
typhimurium on these mice (1), as well as a B cell defect that results in poor or
absent antibody responses to a variety of both thymus-independent (TI)' and
thymus-dependent (TD) antigens, low preimmune serum IgM and IgG3 levels,
failure to form B lymphocyte colonies in soft agar, and failure to be stimulated
by antiimmunoglobulin (reviewed in references 2, 3). These abnormalities in
immune function are presumed to be due to the absence of a late developing
subpopulation of B cells that express the Lyb-3,5, and 7 differentiation antigens
(4-6) . However, T cell and macrophage/accessory cell functions are relatively
normal (1, 3, 7-15) . For example, with regard to immunity to S. typhimurium,
these immune-defective mice have normal salmonella-specific, T cell-dependent
delayed-type hypersensitivity (10) and the normal macrophage-mediated capacity
to contain early net growth of S. typhimurium (1). Previous studies from this
laboratory (10) suggested that susceptibility to S. typhimurium in mice that express
the xid gene is a consequence of a defective anti-S. typhimurium antibody
response. These studies showed that, when compared with normal mice, F, male
immune-defective mice generated relatively low levels of serum anti-S. typhimu-
rium antibodies after immunization with an acetone-killed and dried (AKD)
preparation of S. typhimurium. Furthermore, passive transfer of immune serum
from normal mice could protect F, males from a lethal challenge with live S.
typhimurium . Taken together, these findings suggest that B cells and their
antibody products are important in the development of resistance to S. typhimu-
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rium in these mice, and that susceptibility may be a result of an altered S.
typhimurium-specific B cell repertoire.
Recent studies from our laboratory' have analyzed the primary and secondary
B cell repertoire specific for S. typhimurium in immunologically normal mice
using a modified limiting dilution splenic focus assay. In the present study, we
use this assay system to compare the frequency and reactivity patterns of S.
typhimurium B cells in normal, innately resistant, CBA/Ca mice with those of the
salmonella-susceptible, anti-S. typhimurium antibody-defective CBA/N mice.
The results show: (a) CBA/N mice express no primary or secondary S. typhimu-
rium-specific precursors; (b) after three immunizations, the CBA/N tertiary B
cell frequency is similar to that of primary normal CBA/Ca S. typhimurium-
specific B cells; (c) the percentage of CBA/N tertiary B cells specific for the LPS
molecule is intermediate between that of primary and memory CBA/Ca anti-
LPS antibody-producing clones; (d) fine specificity analysis shows a defective B
cell response to the 2-keto-3-deoxyoctonic acid (KDO)/lipid A region of the LPS
molecule; and (e) the isotypic profile in these mice is altered. Taken together,
these results indicate that CBA/N mice have an abnormal distribution of S.
typhimurium-specific B cells, and suggest that these alterations in the expressed
repertoire may account for the susceptibility of these mice to S. typhimurium.
Materials and Methods
Animals. 6-8-wk-old CBA/Ca, AKR/J, and BIO.BR mice were obtained from The
Jackson Laboratory, Bar Harbor, ME. CBA/CaHN mice were obtained from the National
Institutes of Health, Bethesda, MD. The two sources of CBA/Ca mice were used inter-
changeably. 8-10-wk-old CBA/N mice were obtained from Dominion Laboratories,
Dublin, VA or NIH.
Antigens. Salmonella typhimurium strain TML was originally isolated from a patient
with salmonellosis (16). Organisms were isolated on tryptic soy agar (TSA) plates (Difco
Laboratories Inc., Detroit, MI) grown at 37° C. AKD bacteria of TML were prepared by
the method of Landy (17) and kindly supplied by Dr. Samuel Formal, Walter Reed Army
Institute of Research, Washington, D.C. LPS from TML was prepared by the procedure
of Romeo et al. (18). Streptococcus pneumoniae type 3 was a gift of Dr. John Robbins,
Bureau of Biologics, Bethesda, MD. S. pneumoniae was grown from a single isolated colony
on blood agar plates (Difco Laboratories Inc.) for 16 h at 37 ° C with C02. S. typhimurium
LT-2 and the LPS-deficient mutants his-642 (Ra), HN202 (Rc), SLI004 (Rd]), S11181
(Rd2), and TH2168 (Re) derived from it were the gift of Dr. J. K. Spitznagel, Emory
University, Atlanta, GA. All ofthe bacterial cultures were grown in Penassay broth (Difco
Laboratories Inc.) overnight at 37° C with shaking, from single colonies isolated on TSA
plates. The actual number of organisms present in each culture was determined by serial
dilution of the overnight culture in 0.15 M saline, spreading 0.1 ml on TSA plates, and
overnight incubation at 37°C.
Preparation of Cell Suspensions and Adoptive Cell Transfer.
￿
For T cell depletion of
donor cell populations, washed and counted spleen cell pellets were treated with 0.5 ml
of anti-Thy-1 .2 per spleen (hybridoma HO-13.4) (19), 0 .5 ml of anti-Thy-1 framework
per spleen (hybridoma T24/40 .7) (20), and 1 .0 ml working dilution ofrabbit complement
per spleen (Cederlane Laboratories Ltd., Hornby, Ontario, Canada). Treated spleen cells
were incubated for 15 min at 4°C, then for 30 min at 37°C. The purity of splenic B cell
suspensions obtained by T cell depletion was ascertained by immunofluorescent staining
with fluorescein-conjugated anti-IgM, anti-IgD, and anti-B and analysis on the FACS as
s Metcalf, E. S., M. Gaffney, and L. W. Duran. Diversity of the secondary Salmonella typhimurium-
specific B cell repertoire. Submitted for publication.DURAN AND METCALF
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described by Scher et al. (21). The percentage of B cells within the population was
>95%.
Recipients received 10-60 x 106 viable untreated spleen cells or 10-25 x 106 T-
depleted spleen cells via a lateral tail vein. Generally, pooled cells from several donors
were injected into three to five recipients.
Splenic Focus Technique.
￿
The splenic focus culture system, modified for the stimulation
of B cells specific for S. typhimurium, was previously described.' Briefly, primed recipients
received 1,500 rad of total body irradiation from a cobalt source 4-6 h before cell
transfer. AKR/J recipients were primed intravenously 14, 11, and 7 d before cell transfer
with 10' AKD/TML organisms per mouse, and B10.BR recipients were primed intrave-
nously one time with the same dose of AKD/TML 3 wk before. This priming regimen
was necessary to optimally stimulate Th cells within the respective recipient mouse strains
(data not shown). Recipients were challenged intravenously with a stimulating dose (5 x
107 organisms/mouse) of the inactivated preparation of TML 16 h after cell transfer. 1 h
later, spleens were removed and sliced into 1-mm cube fragments on a McIlwain Tissue
Chopper (Brinkman Instruments Co., Westbury, NY). The fragments were then individ-
ually placed in wells of microtiter plates (Linbro, Flow Laboratories, Inc., McLean, VA)
and incubated in DME supplemented with 10% agamma horse serum and 10 mM
glutamine (Grand Island Biological Co., Grand Island, NY) at 37'C in an atmosphere of
95% 02/5% C02. Culture fluids were removed and replaced with 0.2 ml/well of fresh
complete medium 3 d later, and the medium was changed at 3-4-d intervals thereafter.
Culture fluids collected 10-23 d after stimulation were assayed for anti-TML antibody,
H chain class of antibody, and fine specificity of the antibody.' Collected culture fluids
from individual wells were stored at -20°C until time of assay.
Radioimmunoassay.
￿
The RIA of culture fluids (50 ul) for specific mouse anti-TML
antibody on bacteria-coated microtiter plates was previously described (22). TML' culture
fluids were reanalyzed in microtiter wells coated with 50 Ad of purified TML-LPS diluted
in phosphate buffer at a concentration of 100 ng LPS/well (23). Positive culture fluids
were also reanalyzed for isotype(s) with the same RIA procedure and the following
affinity-purified, class-specific rabbit anti-mouse antibodies: (a) anti-IgM; (b) anti-IgG3;
(c) anti-IgGI ; (d) anti-IgG' ; and (e) anti-IgA. The preparation and specificity of these
reagents have been described elsewhere (23).
Statistical Analysis.
￿
Statistical analysis was performed using Student's two-tailed t test
for independent means.
Results
Serum Antibody Responses to AKD-TML.
￿
Immune-defective CBA/N mice have
low preimmune serum IgM and IgG3 levels (24, 25). Previous studies from this
laboratory (10) demonstrated that both salmonella-resistant, immunologically
normal (CBA/N x DBA/2N)F, female and salmonella-susceptible immune-de-
fective F, male mice make similar IgM anti-TML serum antibodies after immu-
nization with AKD-TML; however, IgG titers at 3 and 4 wk after immunization
were much lower in the F, male mice . To further characterize the anti-TML
antibody response in immune-defective mice, serum samples from CBA/N mice
and CBA/Ca controls were analyzed by RIA to determine the LPS specificity
and the isotypes 4 wk after immunization with 5 x 108 AKD-TML organisms.
Fig. 1 A shows the geometric mean titers of anti-TML antibodies in CBA/Ca and
CBA/N mice. These results suggest that the anti-TML IgG response in CBA/N
mice is significantly (p <0.05) reduced when compared with CBA/Ca mice; the
data are also consistent with the results of O'Brien et al. (10) and Metcalf et al.8
3 Metcalf, E. S., and A. D. O'Brien. Mice with early and late genetic defects in immune responses
to Salmonella typhimurium can be protected by a live, avirulent vaccine. Submitted for publication.32
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TABLE I
Comparison of the Frequency ofPrimary TML-specific B Cells in CBA/Ca and CBA/N Mice
*Spleencellswere treated with T24/40 .7 anti-Thy-1 plus H043.4 anti-Thy-1 .2 plus rabbit comple-
ment as outlined in Materialsand Methods.
t 10-25 X 106 anti-Thy-1 + C-treated CBA/N or CBA/Ca spleen cells and 30 X 106 untreated
CBA/N spleens were injected into B10.BRrecipients that hadbeen previouslyprimed intravenously
with 106 AKD/TML organisms 3 wk before cell transfer. Stimulation of recipients and detection
of clones by RIA were as described in Materials and Methods.
1Calculated frequencies afterhoming efficiency and percentof B cells in the spleen were taken into
account. The number of B cells in the spleens of CBA/Ca and CBA/N donor mice was 40 and
20%, respectively (7, 26).
In addition, the majority ofthe anti-LPS antibody activity (Fig. 1B) is in the IgG
fraction in CBA/Ca mice and in the IgM fraction in CBA/N mice . Moreover,
subclass analysis of the IgG serum component of the anti-LPS antibody response
(Fig. 1 C) shows that all subclasses are reduced (p <0.05) in CBA/N mice, but
the IgG3 fraction is the most reduced. These results confirm and extend the
findings of O'Brien et al. (10) and are consistent with the idea that the suscepti-
bility of mice that express the xid defect to S. typhimurium is a consequence ofa
delayed and diminished anti-S. typhimurium antibody response.
Frequency ofS. typhimurium-speck B Cells.
￿
One possible explanation for the
decreased antibody responses in CBA/N mice is that these mice have a reduced
number of salmonella-specific precursor B cells. To address this issue, spleen
cells from CBA/N and CBA/Ca mice were compared in the modified splenic
focus system described in Materialsand Methods. Since CBA/N mice have fewer
splenic B cells (7), donor spleen cells from both strains were treated with anti-
Thy-1 and C before cell transfer so that equal numbers of CBA/N and CBA/Ca
B cells could be transferred to recipients. Table I showsa representative example
of such an experiment. Whereas the primary S. typhimurium strain TML-specific
precursor frequency in CBA/Ca spleens was 6.68/106 B cells, not a single TML-
specific clone was detected in a total of 225 X 106 CBA/N B cells analyzed. In
one experiment, we detected one clone in 60 X 106 CBA/N unfractionated
spleen cells. However, after analysis of an additional 320 X 106 CBA/N spleen
cells, where as many as 60 X 106 unfractionated cells were transferred to one
recipient, we detected no other TML-specific clones (data not shown). Thus,
CBA/N spleens appear to contain either very few primary Ig-secreting TML-
specific B cells or none at all. To ascertain that this lack of responsiveness was
not due to the preparation ofS. typhimurium used for stimulation, CBA/N spleen
cells were stimulated with a live, avirulent, temperature-sensitive mutant of
TML, TS-27. Again, only one clone wasfound in 270 X 106 spleen cellsanalyzed
(Metcalf, E. S., unpublished data).
Number of Number of
Total num- TML-spe- TML-spe-
Donor Treatment* ber of cells
transferred cific clones cificcells
106
(X10-6) per 106cells
transferred*
per
splenic B
cells
CBA/Ca Anti-Thy-1 +C 30 0.27 6.68
CBA/N - 60 0.02 0.43
CBA/N Anti-Thy-1 + C 225 0.00 0.0034
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TABLE II
Secondary and Tertiary TML-specific PrecursorFrequency in CBA/Ca and CBA/NMice
* CBA/N and CBA/Ca mice were immunized, i.v., with 108 AKD-TML organisms in saline either
once 6 wk before, or twice, 6 and 2 wk before serving as a source ofdonorcells.
5 x 106 CBA/Ca or 5-20 x 106 CBA/N donorspleen cells were injected into AKD-TML-primed
recipients. Priming and stimulation of recipients and detection of clones by RIA are as described
in Materials and Methods. Data are presented as mean frequency± 2 SE.
¢Calculated frequencies afterhoming efficiency and percent of Bcells in the spleen were taken into
account. The number of B cells in the spleens of CBA/Ca and CBA/N donor mice was 40 and
20%, respectively (7, 26).
In previous studies from this laboratory (27), CBA/N mice did not appear to
beable to generate primary PC-specific B cells. Nevertheless, after immunization,
we detected a small number ofPC-specific B cell precursors in these mice. Thus,
we assessed the capacity of CBA/N mice to generate secondary AKD-TML-
specific B cells. Table II shows that CBA/N donor spleen cells transferred 6 wk
after immunization with 108 AKD-TML organisms still do not give rise to
detectable clones after secondary challenge. On the other hand, the secondary
precursor frequency for CBA/Ca control spleen cells is 1.96 per 106 spleen cells,
a 13-fold increase over the primary precursor frequency (27a). However, CBA/N
donor spleen cells that have been immunized once 6 wk before then again 2 wk
before cell transfer with 108 AKD/TML organisms give rise to TML-specific
precursors with a frequency of0.12 per 106 spleen cellsafterthe third challenge.
This frequency is 23-fold lower than the frequency obtained for tertiary TML-
specific precursors in CBA/Ca controls (Table II, cf., lines3and 4), but markedly
similar to the primary precursor frequency in immunologically normal CBA/Ca
mice' (also see Table V). Additional priming of CBA/N mice did not result in
an increased frequency (Metcalf, E. S., data not shown) . Thus, these findings are
consistent with our previous studies that suggested that CBA/N B cells may need
to undergo further differentiation before they can secrete antibody (27).
It is not yet clear if the inability to detect primary anti-TML precursors in
CBA/N mice is due to the failure of primary CBA/N TML-specific B cells to
respond in the splenic focus system or whether it is simply due to suboptimal
conditions for stimulation of these B cells. This latter possibility seems unlikely
because conditions for stimulation ofDNP-specific precursors in immune-defec-
tiveandnormal mice have been shown to be identical (28). In addition, secondary
PC-specific precursors and (T,G)-A--L precursors are detectable in the splenic
focus system under the same conditions in which primary precursors are not
detectable (3, 27).
Isotype Analysis ofAnti-TML-specific mAbs.
￿
A second possible explanation for
Source of Cells
Donor Prim-
ing with
AKD/TML*
Wk
Total num-
ber of cells
transferred
(x 10-6)
Number of TML-
clones
106
specific per
cells transferred*
Number TML-spe-
cific cellsper 106
Splenic B cells¢
CBA/Ca -6 45 1.96 t 0.12 122.5 ± 7.3
CBA/N -6 55 0 0
CBA/Ca -6-2 40 2.85 ± 0.43 178.1 ± 27.0
CBA/N -6-2 310 0.12 ± 0.01 15.4 ± 1.8DURAN AND METCALF
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TABLE III
Proportion of Clonesfrom Tertiary TML-specific CBA/N B Cells Secreting Particular Isotypes
* Primed CBA/N and CBA/Ca donors were immunized as described in the footnotes of Table II.
TML-specific clones from primed CBA/N and CBA/Ca and unprimed CBA/Ca spleens were
obtained from fragment cultures derivedfrom AKD/TML-primed and-irradiated AKRor BlO.BR
recipients.
$ Anti-TML clones were analyzed for the isotype produced by RIA against whole TML organisms
using rabbit anti-mouse H chain-specific sera. Data from unprimed CBA/Ca donor cells are
repeated from Duran and Metcalf(27a).
TABLE IV
Number ofIsotypes Secreted by Clonesfrom Tertiary TML-specific CBA/N B Cells
* Primed CBA/N and CBA/Ca donors were immunized as described in Table II. TML-specific
clones from primed CBA/N and CBA/Ca and unprimed CBA/Ca spleens were obtained from
fragment cultures derived from AKD-TML-primed AKR or B10.BR recipients. Data from un-
primed CBA/Ca donorcells are repeated from Duran and Metcalf(27a).
the susceptibility of CBA/N mice to S. typhimurium may be an altered isotype
distribution pattern. Therefore, we analyzed the isotype profile of tertiary TML-
specific clones from CBA/N mice (Table 111). In contrast to either the primary
or memory CBA/Ca response, the majority of the CBA/N clones secrete IgG2
anti-TML antibody. Since CBA/N mice normally have low levels of serum IgG3
(24, 25) and are unresponsive to antigens that stimulate IgG3 production (29),
it is not surprising that none of the CBA/N-derived clones secrete the IgG3
subclass. In addition, only a small proportion of these clones secrete either IgA
or IgM anti-TML antibodies. These results indicate that, although the tertiary
TML-specific precursor frequency in CBA/N mice is similar to the frequency of
primary CBA/Ca B cells, the distribution of the isotypes secreted from such
clones is markedly different. Further, although the CBA/N TML-specific clones
can be generated after a third challenge with AKD-TML, their isotype profile is
also markedly different from that of CBA/Ca memory anti-TML B cell clones.
It is also possible that an altered response to TML may be a reflection of the
number of different isotypes secreted by CBA/N B cells. Therefore, in Table
IV the number of different isotypes secreted by individual clones derived from
CBA/N mice is compared with the number secreted from CBA/Ca primary and
memory TML-specific foci . It is important to note that Poisson distribution
analysis of our data indicated that the majority of fragments that secrete more
Donor cells*
Percent
1
of individual
2
clones secreting
different
3
the following
isotypes:
4
number of
5
Primed CBA/N 80.4 15.2 4.3 0 0
Unprimed CBA/Ca 72.2 21 .5 5.7 0.6 0
Primed CBA/Ca 27.4 34.1 21 .6 13.9 4.3
DonorCells*
IgM
Percent
IgG3
of clones
IgGI
secreting:$
IgG2 IgA
Primed CBA/N 8.7 0.0 28.3 73.9 13.0
Unprimed CBA/Ca 75.3 9.5 3.8 22.2 23.4
Primed CBA/Ca 71 .6 23.1 35.6 57.7 44.736
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than one H chain class contain only one TML-specific B cell.' Much like the
CBA/Ca primary anti-TML clones, most CBA/N clones secrete only one isotype
with a few secreting two or three isotypes. However, differences between these
two B cell subpopulations can be observed. One difference, aside from the lack
of IgG3-secreting clones, is that more than half of the CBA/N IgGI anti-TML
antibodies are secreted in the absence of other isotypes, and the remainder of
the clones that secrete IgGI antibodies do so with only one additional isotype
(data not shown). Conversely, CBA/Ca primary IgGI anti-TML antibodies tend
to be secreted with most of the isotypes (27a). A third difference is that the
predominant isotype secreted by CBA/N clones is IgG2 (see Table III). More-
over, the majority of these clones secrete solely IgG2 anti-TML antibody.
CBA/Ca primary clones, on the other hand, secrete IgG2 antibodies with at least
one other isotype (27a).
As mentioned above, even after three immunizations the isotype profile of
CBA/N TML-specific clones differs drastically from that of CBA/Ca memory
clones. Tables III and IV indicate that CBA/Ca memory TML-specific B cells
have undergone considerable differentiation after two and three immunizations.
Indeed, the majority of these clones from normal mice secrete each isotype in
combination with most of the other isotypes to a much higher degree than the
CBA/Ca primary clones. In contrast, the majority of CBA/N clones that secrete
each isotype, secrete only that isotype. The paucity of IgM anti-TML antibodies
suggests that these TML-specific precursors have, indeed, differentiated into
memory cells. However, the switching pathway appears to be different from that
of CBA/Ca memory TML-specific B cell precursors.
Fine Specificity Analysis ofSplenic TML-specific B Cells in CBA/N Mice.
￿
Previous
studies have shown that bacterial carbohydrates stimulated antibody responses
predominantly of the IgM and IgG3 isotypes (30), and that CBA/N mice are
unresponsive to such antigens (29). Thus, it is surprising to find that CBA/N
mice can elicit an LPS-specific anti-TML serum antibody response (Fig. 1).
However, when the splenic TML-specific B cell repertoire is analyzed, the IgG3
subclass represents less than a quarter of the total CBA/Ca memory anti-TML
antibody response (Table III) that is almost entirely LPS-specific (27a).' Hence,
contrary to the findings of Slack et al. (29), B cell subsets other than those
restricted to the IgM and IgG3 isotypes may be capable of responding to LPS,
at least when presented to the host on the surface of the TML bacterium. These
subsets, then, are probably responsible for the anti-LPS response in CBA/N
mice. Because previous studies' suggest that the LPS-specific response is impor-
tant in the memory response to salmonella infections in normal mice, and because
CBA/N mice are susceptible to salmonella, it was of interest to determine what
proportion of the total anti-TML antibody response was contributed by clones
specific for LPS . Table V shows that 69.6% of the CBA/N TML-specific clones
reacted with LPS in an RIA. In addition, none of these clones reacted with the
negative control S. pneumoniae (data not shown) . Therefore, although the fre-
quency of TML-specific precursors is similar in unprimed CBA/Ca mice and
primed CBA/N mice, the proportion of anti-LPS antibodies is over twofold
lower in unprimed, normal CBA/Ca mice, and 22% of the anti-TML response
in CBA/Ca mice is crossreactive with S. pneumoniae. The frequency of LPS-DURAN AND METCALF
TABLE V
LPS Specificity ofTML+ Clonesfrom Tertiary CBA/NSpleen Cells
Number of
￿
Percent of anti-
TML-specific
￿
TML antibody
Donorcells*
￿
clones per 108 ￿clones reactive
cellstrans-
￿
with TML-
ferre& LPSI
Primed CBA/N
￿
0.12
￿
69.6
Unprimed CBA/Ca
￿
0.15
￿
28.6
Primed CBA/Ca
￿
2.85
￿
96.6
* Primed CBA/N and CBA/Ca donors were immunized as described in
Table II,
$ Frequencies for primed CBA/N and CBA/Ca cells are from Table II.
Freuency for unprimed CBA/Ca spleen cells is from Duran and Met-
calf.'
§Anti-TML+clones in fragment cultures derivedfrom recipients primed
with AKD/TML were assayed in a solid phase RIA with either TML-
LPS or S. pneumoniae as the immunoadsorbent.
TABLE VI
Fine Specificity of Anti-LPS Antibodiesfrom CBA/N TML-specific Clones
37
* Anti-TML' clones reactive with LPS were reanalyzed using wholeS. typhimurium rough mutant
organismsas immunoadsorbents. Data from unprimed andprimed CBA/Ca donorcells arerepeated
from Duran and Metcalf(27a).
specific clones in tertiary primed CBA/N micehas an intermediate value between
unprimed and primed CBA/Ca mice.
The TML-specific clones from CBA/N mice shown to be reactive with LPS
were analyzed further for reactivity with a series ofO antigen-deficient, rough
S. typhimurium mutants. These mutant strains synthesize an incomplete LPS
molecule . For example, the Ra polysaccharide represents the complete basal core
polysaccharide of the parental, smooth polysaccharide . However, the Rc-Re
mutants produce progressively more incomplete core polysaccharides, with the
Re mutant expressing only the KDO molecule and lipid A. It was anticipated
that discrete patterns of reactivity could possibly elucidate the susceptibility of
CBA/N mice to S. typhimurium. The results ofsuch ananalysis oftertiary CBA/N
B cell products are compared with the responses of unprimed and primed
CBA/Ca mice in Table VI. The results indicate that 67.7% of the TML-LPS-
Immunoadsor- Percenttotal LPS+ clones with the following reactivity
bent: pattern:
LPS + + + + +
Ra - + + + +
Rc - - + + +
Rdl - - - + +
Rd2 - - - - +
Re - - - - -
Source ofCells
Primed CBA/N 67.7 12.9 0 3.2 0 16.1
Unprimed CBA/Ca 72.1 0 0 1.9 0 26 .0
Primed CBA/Ca 43.7 2.0 1.5 3.0 5.5 44.238
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FIGURE 2 .
￿
Comparisonof fine specificity ofLPS-specific B cell clones in normal and antibody-
defective mice . TML-specific clones from primed CBA/N and from unprimed and primed
CBA/Ca mice were compared by RIA using LPSand a series of S . typhimurium rough mutants
as immunoadsorbents . The entire bar represents the percent of the total anti-TML B cell
clones that are reactive with LPS . The solid bar represents the percent of the total anti-TML
B cell clones that are directed to theO antigen, the striped bar represents the percent that are
directed to core polysaccharides, and the open area of the bar represents the percent ofclones
that react with KDO/lipid A determinants .
specific precursors from primed CBA/N mice react only with the whole organism
and do not react with any of the rough mutants tested . 13% of the clones
recognize a site somewhere within the LPS outer core polysaccharide region
(Ra+), and 3.2% recognize a site in the inner core region (Rdl'') . Finally, only
16% react with all the tested rough mutants . These results are similar to the
reactivity pattern observed after analysis of primary TML/LPS-specific clones
from normal CBA/Ca mice . However, both responses are considerably different
from the reactivity pattern of primed CBA/Ca mice . This is more clearly
illustrated in Fig . 2 . Whereas the majority of the primed CBA/N anti-LPS
antibodies are directed against the 0-antigen and only a small proportion is
directed against the KDO/lipid A region, less than half of the CBA/Ca memory
anti-LPS antibodies are O antigen-specific, and nearly half are KDO/lipid A-
specific . Thus, the fine specificity profiles o£ anti-TML antibodies in CBA/N
mice are distinct from those of normal mice . Alterations have also been observed
in the fine specificity patterns of anti-(T,G)-A--L antibodies in CBA/N mice (3) .
The results suggest that while the primed B cell subset in immune-defective
CBA/N mice (presumably Lyb-5- [5]) can produce anti-LPS antibodies, these
antibodies are predominantly O antigen-specific, reminiscent of the primary
TML-specific B cell repertoire . Therefore, the anti-O antigen antibodies from
primed normal CBA/Ca mice presumably arise from both the Lyb-5- and the
Lyb-5' B cell subsets, whereas anti-lipid A antibodies primarily arise from Lyb-
5' B cells . An analysis of additional CBA/N clones may clarify the differences in
LPS reactivity between the three responses . For example, this interpretation of
the results would predict that the proportion ofO antigen-specific clones would
increase and the proportion of lipid A-specific clones would decrease for tertiary
LPS-specific CBA/N B cells . Additionally, treatment of primed CBA/Ca spleen
cells with anti-Lyb-5 antibody andC should effectively diminish the anti-lipidADURAN AND METCALF
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component of the memory anti-TML antibody response if this hypothesis is
correct.
Lyb-5- B cells also appear to respond to antigenic determinants other than
LPS (Table V). Moreover, since primary TML-specific precursors from CBA/N
mice do not respond in the splenic focus system and because >70% of the
primary precursors from normal CBA/Ca mice do not react with LPS, it is
deduced that Lyb-5+ B cells also produce antibodies against other salmonellae
components. Whether the reactivity patterns of these antibodies directed against
other salmonellae cell surface antigens distinguishes CBA/N responses from
CBA/Ca responses remains to be determined. Nonetheless, the altered fine
specificity pattern of the anti-TML antibodies in these mice may influence the
ability of CBA/N mice to respond to S. typhimurium .
Discussion
In this paper, the S. typhimurium strain TML-specific B cell repertoire of
normal, innately resistant CBA/Ca mice was compared with that of genetically
susceptible, anti-S. typhimurium antibody-defective CBA/N mice, which are a
mutant subline of CBA/CaHN mice (2). These studies were undertaken to
provide insights on the role of B cells in resistance to murine typhoid and on the
genetics and immune mechanisms responsible for the differential susceptibility
to this bacterial infectious disease agent. The results show that the frequency,
isotype distribution patterns, and fine specificity analysis of CBA/N B cells appear
to be abnormal and may account for the susceptibility of these mice to TML.
CBA/N mice do not express primary TML-specific precursors nor do they
express secondary precursors after priming with AKD-TML. However, after
three immunizations, the CBA/N tertiary precursor frequency is detectable.
Although this frequency is similar in magnitude to that of primary CBA/Ca
TML-specific B cells, the isotype profile and fine specificity of the two responses
are characteristically different. Further, the tertiary CBA/N B cells appear to be
memory cell-like in nature since: (a) very little IgM antibody is produced; (b) the
proportion of IgG 1 and IgG2 antibodies is much higher than in the primary
CBA/Ca response; and (c) the majority of the anti-TML antibody is LPS-specific.
Yet, these cells are still quantitatively and qualitatively different from CBA/Ca
memory precursor cells immunized with the same regimen.
Although the majority of the memory CBA/Ca anti-TML response is LPS
specific, almost half ofthe B cells are directed against the KDO or lipid A moiety.
In contrast, only a few tertiary CBA/N clones are specific for this portion of the
LPS molecule, and the majority are reactive against the O antigen region only.
In addition, none of the CBA/N clones were reactive against S. pneumoniae.
These results suggest that KDO/lipid A-specific and S. pneumoniae-crossreactive
precursors may be restricted to the Lyb-5+ B cell subset. Lyb-5- B cells, which
have the characteristics of an immature B cell subset, are easily tolerizable (2,
28). Therefore, this restriction is compatible with the idea that lipid A could
tolerize Lyb-5- B cells since the lipid A region is structurally similar in most
gram-negative bacterial organisms (31), and because LPS is released into the
surrounding environment (32). Lyb-5' B cells, on the other hand, are a mature
B cell subset and are not tolerizable (2, 28).40
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Previous results from this laboratory offer an hypothesis that explains: (a) the
inability to activate primary Lyb-5- B cell precursors responsive to PC in splenic
focus cultures; (b) the ability to generate a delayed in vivo primary IgG anti-PC
response but not an IgM response; and (c) theability to activate in vitro secondary
anti-PC B cell precursors (27). Our results suggested that PC-specific precursors
in immune-defective mice must differentiate into memory cells before they can
be activated to secrete antibody. We envisaged different activation requirements
for Lyb-5- and Lyb-5+ PC-specific cells. Consequently, we presumed that the
splenic focus system may not provide all the necessary activation signals to
primary Lyb-5- PC-specific B cells. The results presented here for TML-specific
responses in immune-defective mice are remarkably similar to those of PC-
specific responses in these mice. Thus, in accordance with this hypothesis, we
can postulate that Lyb-5- TML-specific B cells, upon primary stimulation, cannot
secrete antibody because they cannot receive the appropriate helper cell signal(s)
that induces maturation to Ig secretion. However, these precursors can receive
the helper signal(s) that activate(s) memory B cell formation. After repeated
immunizations, class switching events proceed to some extent, and these Lyb-5-
B cells acquire a receptor for helper cell maturation signal(s). Therefore, secre-
tion of anti-TML antibody can begin. As opposed to the Lyb-5- B cell subset,
unprimed Lyb-5' B cells, being a more mature subset (2), can secrete antibody
after only a single immunization . Since Lyb-5+ cells express receptors for both
the proliferation signal(s) and maturation signal(s), they can secrete antibody
before class-switching events have occurred . Thus, IgM anti-TML antibody is
likely to be found in responses of Lyb-5+ B cells but not in those of Lyb-5- B
cells. This is supported by the data presented in Table 111. This delay in antibody
production by Lyb-5- B cells may contribute to the susceptibility of CBA/N to
S. typhimurium infection.
Recent studies (reviewed in 33) have shown that activation of Lyb-5- and Lyb-
5+ B cells requires very different cellular interactions, even when responding to
the same antigen and when activated by the same cloned population of Th cells.
Furthermore, studies from this laboratory (34, 35), have provided evidence that
suggests that T cells can supply additional proliferative signals that enhance
switching events within expanding B cell clones. Moreover, the results herein
suggest that although TML-specific B cell precursors in immune-defective mice
may possess a receptor for the Th signal(s) that activates differentiation, isotype-
switching events within these cells are mediated by a pathway(s) distinct from
that of normal TML-specific B cells. It appears that after stimulation of CBA/Ca
mice by AKD-TML, proliferation of an IgM+ precursor cell ensues, followed by
varying degrees of isotype switching within separate daughter cells of the B cell
clone. Whether these switches from IgM to other isotypes occur as sequential
events within one lineage of daughter cells or as distinct events within separate
daughter cells is not clear. However, these data suggest that, unlike TNP/Ficoll
(34, 35), AKD-TML induces distinct switching pathways since there is no appar-
ent correlation between the frequency of clones secreting each isotype and the
5'-3' IgCH gene order. There has been evidence that both sequential and
distinct switching events can occur within clones of cells derived from single PC-
specific B cells (36) .DURAN AND METCALF
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Nevertheless, whatever the mechanism, AKD-TML-stimulated normal B cells
can undergo successive H chain class switches that yield expression of all five
isotypes at some point in time . Upon repeated immunization, switches occur
more frequently. In contrast, there appears to be only one switching pathway in
immune-defective mice . Although switches to the IgG2 isotype predominate in
memory CBA/Ca B cell clones, this isotype is generally secreted with other
isotypes. The isotype pattern expressed by tertiary CBA/N clones indicates that
a single distinct IgM --> IgG2 switching pathway exists for these (putative Lyb
5-) TML-specific B cells. Occasional switches to other isotypes may occur to a
minor extent, which would account for the low levels of these isotypes observed .
This implies that CBA/N B cells lack a receptor(s) for helper switch signals that
mediate the expression ofother isotypes. Although not examined in these studies,
results of past studies (37, 38) suggest that a distinct IgE switching pathway may
also exist in immune-defective mice, since these mice produced significant levels
of primary IgE anti-PC serum antibody and only poor levels of IgM, IgG, and
IgA anti-PC antibodies. The likelihood that independent, IgG, IgA, and IgE
switch pathways can occur has been substantiated by several independent lines
of evidence (34-36, 39-41) . Alternatively, normal switching events within
CBA/N TML-specific B cells may occur, but normal secretion of Ig by these
cells may not. Woloschak4 has provided evidence that B cells from CBA/N mice
have normal levels of H chain isotype-specific mRNA accumulation and tran-
scription. However, CBA/N resting splenic B cells were found to have a marked
deficiency of mRNA encoding the secreted form of a H chain.
Collectively, these data suggest several factors that may be involved in the xid-
conferred susceptibility of CBA/N mice to S. typhimurium infection. The original
premise was that CBA/N mice may contain a reduced number of salmonella-
specific B cell precursors. Through the use of the splenic focus system, we
attempted to determine the frequency of such cells. Our results show that they
do not have primary or secondary Ig-secreting B cell precursors. In addition, the
frequency of tertiary immune-defective precursors is 23-fold lower than tertiary
precursors in normal CBA/Ca mice. However, Clough et al. (37) have shown
that after repeated immunization the frequency of PC-specific precursors in
immune-defective mice was nearly equivalent to that in normal mice . The
similarities between the responses to TML and PC by these mice is striking.
Therefore, it was anticipated that after more immunizations, the frequency of
TML-specific precursors in immune-defective mice would also begin to approach
the frequency seen in normal mice . However, even after five rounds of AKD-
TML challenge, the frequency within these mice increased only slightly (Metcalf,
E. S., data not shown). Therefore, the delayed development of these cells appears
to be a very important factor in the susceptibility of these mice to infection. It
has been proposed that Lyb-5+ PC-specific precursors are responsible for the
primary in vivo response and that the Lyb-5- subset only plays a role in the
secondary in vivo anti-PC response (27). Again, the results of the TML-specific
response in CBA/N mice are compatible with this hypothesis. However, it has
not been shown if, in fact, primary Lyb-5- B cells from normal CBA/Ca mice
° Woloschak, G. E. Immunoglobulin gene expression in xidmice: defective expression of secreted
and membrane a-heavychain RNA. Submitted forpublication.42
￿
ALTERED SALMONELLA-SPECIFIC CBA/N B CELL REPERTOIRE
can respond to AKD-TML in the splenic focus system . It is possible that the Lyb-
5- B cell subset may be composed of two populations; one, which has more
stringent activation requirements, is present in both CBA/Ca and CBA/N mice,
and one, which has similar activation requirements as Lyb-5+ B cells, is present
only in CBA/Ca mice. Other studies (28, 42, 43) have provided evidence that
supports the existence of two Lyb-5- subsets. Instead of two distinct Lyb-5-
subsets, the xid gene may also exert its control on the activation of Lyb-5- B
cells. Thus, primary Lyb-5- TML-specific B cells from normal mice would be
detectable. However, this is unlikely since primary PC-specific Lyb-5- B cells
from normal mice areundetectable (27). Although Lyb-5- Bcells maybe involved
only in secondary responses, by themselves these Bcellsare apparently ineffective
in providing resistance to S. typhimurium infection. Ostensibly, ifsecondary Lyb-
5' TML-specific B cells are more easily activated, this subset would be able to
keep the infecting salmonellae in check until anti-TML antibody production
occurs by the Lyb-5- B cell subset. In immune-defective mice the development
of these antibodies may be too late. In addition, without anti-TML antibodies
produced by Lyb-5' B cells, those derived from Lyb-5- B cells may be ineffective
in handling the infection.
The data presented here indicate that the anti-TML repertoire in immune-
defective mice may be lacking a very important subset of TML-specific B cells.
In spite of the fact that the majority of anti-TML antibodies derived from
CBA/N mice are LPS specific, only a small proportion are KDO/lipid A specific .
Because almost halfto two-thirds of the LPS-specific anti-TML antibodies from
normal, memory CBA/Ca clones are directed to KDO/lipid A (Table VI), this
deficiency in immune-defective mice may be deleterious. Although anti-O anti-
gen antibodies may be important to long-term immunity (44), these findings
(summarized in Fig. 2) suggest that the development of these antibodies in
immune-defective mice is not enough for protective immunity. Following from
the discussion in the preceding paragraph, without the anti-lipid A antibodies
that are primarily produced by Lyb-5+ B cells, the anti-O antigen antibodies
derived from Lyb-5- B cells may not be able to control the infection. CBA/N
mice also appear to be lacking another subset ofTML-specific B cells, although
this subset and the KDO/lipid A-specific subset may not be mutually exclusive.
This missing subset of B cell precursors has the capacity to switch to and/or
secrete isotypes other than IgG2. The comparison of the CBA/Ca and CBA/N
repertoires demonstrates that IgG2 anti-TML antibody is predominant in the
normal primary and memory responses, and that Lyb-5- B cells are presumably
responsible for the increase in IgG2 production in memory responses. However,
it appears that those B cells whose clonal progeny can express other isotypes by
class-switching events are also important in the memory response of normal,
resistant mice.
Taken together, the studies presented in this report demonstrate that the S.
typhimurium-specific B cell pool in salmonella-susceptible, antibody-defective
CBA/N mice is, at least, skewed, and suggests that these mice may: (a) be missing
an important subset ofS. typhimurium B cells, those specific for the KDO/lipid A
region ofthe LPS molecule ; and (b) not be able to receive the appropriate signals
from other cells that permit the B cells to switch to a class of antibody that isDURAN AND METCALF
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protective. This combination of defects may be the basis for the susceptibility of
CBA/N mice to S. typhimurium. In any case, the TML-specific B cell repertoire
in CBA/N mice is different from that in CBA/Ca mice. Whether the differences
outlined in this communication are the only factors involved in the susceptibility
of these animals to S. typhimurium remains to be determined. Additional defi-
ciencies in the CBA/N precursor pool may become apparent as B cell clones are
further analyzed on a more extensive panel of purified bacterial cell surface
antigens. Such studies are currently underway.
Summary
CBA/N mice, which express the X-linked immunodeficiency gene xid, are
susceptible to Salmonella typhimurium. The basis for this susceptibility is currently
unknown. However, previous studies (10) from this laboratory have provided
evidence that susceptibility may be due to a defective anti-S. typhimurium anti-
body response . In that report we hypothesized that the defective antibody
response may be a reflection of an altered S. typhimurium-specific B cell reper-
toire. In the studies described here, we have investigated this hypothesis using a
modification of the in vitro splenic focus system. The frequency and character-
istics of salmonella-specific B cells in normal, innately resistant, CBA/Ca mice
have been compared with those of salmonella-susceptible, anti-S. typhimurium
antibody-defective CBA/N mice. The results show that CBA/N mice express no
primary or secondary S. typhimurium-specific B cell precursors after stimulation
with an acetone-killed and dried (AKD) preparation of S. typhimurium strain
TML. However, after three immunizations, the CBA/N tertiary frequency of
15.4 per 106 splenic B cells was similar to the primary precursor frequency in
immunologically normal CBA/Ca mice, but 23-fold lower than the tertiary
precursor frequency in CBA/Ca control mice. Moreover, CBA/N mice had an
altered isotype distribution pattern after stimulation with AKD-TML. >70% of
the tertiary CBA/N TML-specific B cells secreted IgG2, in contrast to either
nonimmune or primed control mice. In addition, 80% of the CBA/N TML-
specific B cells secreted only a single isotype, whereas the majority of B cells
from primed normal mice secreted multiple isotypes. Fine specificity analysis of
the TML-specific B cells indicated that the array of antigenic determinants to
which CBA/N B cells could respond was restricted. Although the majority of
primed CBA/Ca and primed CBA/N B cells were specific for LPS, the fine
specificity pattern exhibited by CBA/N B cells was similar to that observed in
unprimed normal mice, i. e., the vast majority were specific for the O antigen
region of the LPS molecule. In contrast, a major portion of the LPS-specific B
cells in primed CBA/Ca mice were directed against the KDO/lipid A region of
the LPS molecule. Therefore, it appears that CBA/N mice lack or are unable to
stimulate the B cell subset that predominates in primed, normal mice. Taken
together, these studies indicate that the basis for susceptibility of CBA/N mice
to S. typhimurium is multifactorial and suggests that the inability of some animals
to respond to some infectious agents may be related to holes in their B cell
repertoire.
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